Effect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study

In this study, the efficacy of an IL-6 antagonist, Tocilizumab, administered in the early period was studied in intensive care patients with COVID-19 pneumonia followed by hypoxic and systemic inflammation not receiving mechanical ventilation support. Patients with COVID-19 pneumonia who have signs...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	TURKISH JOURNAL OF MEDICAL SCIENCES 2022-02, Vol.52 (1), p.39-49
Hauptverfasser:	Küçük, Mehtap Pehlivanlar, Küçük, Ahmet Oğuzhan, Pehlivanlar, Ayşegül, Mürtezaoğlu, Sevil Ayaydın, Çoban, Kadir, Kılıç, Gamze, Ayçiçek, Olcay, Öztuna, Funda, Bülbül, Yılmaz, Özlü, Tevfik
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized COVID-19 Drug Treatment Critical Care Humans Inflammation Interleukin-6 Respiratory Insufficiency - therapy Retrospective Studies SARS-CoV-2 Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!